Variations in the NAT2 gene can lead to different acetylation statuses among individuals, which can influence their susceptibility to drug-induced hepatotoxicity, particularly in the context of ...

Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...

Perhexiline is an antianginal medication used in refractory disease. Despite being highly efficacious, it is seldom prescribed due to its risk of neurotoxicity and hepatotoxicity. These adverse ...

The newest treatment for AUD, acamprosate (Campral) was developed in France. The FDA approved the drug for abstinence ...

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with ...

Glucarpidase significantly improved kidney function for patients who developed acute kidney injury from high-dose ...

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...

1反映肝细胞实质损伤的指标 丙氨酸氨基转氨酶（ALT）ALT（正常参考值为 0 ~ 40 ...

USA: The American Glaucoma Society (AGS) and the American Academy of Ophthalmology (AAO) have issued a position statement ...

Lilly has also submitted marketing applications for Mirikizumab-mrkz in Crohn’s disease around the globe, including in the ...

Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes ...

After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.